Novo Nordisk for Alzheimer's Disease
- 55-85 years old
- Diagnosed with early symptomatic Alzheimer's disease
Okanagan Clinical Trials is seeking volunteers with early symptomatic Alzheimer's disease to take part in a new research study of an investigational medication for this indication. Men and women between the ages of 55 to 85 years may be eligible to participate.
All study-related care and investigational medication will be provided at no cost, and you may be compensated for your time and travel.